-
Mashup Score: 0Clinical Pediatrics - Volume 63, Number 2, Feb 01, 2024 - 3 month(s) ago
Table of contents for Clinical Pediatrics, 63, 2, Feb 01, 2024
Source: journals.sagepub.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 1
By: Anjali Advani, MD Date: 12/06/2023 Dive into this insightful conversation with Dr. Anjali Advani, a distinguished medical oncologist and professor specializing in hemologic oncology and blood disorders at the Cleveland Clinic. Dr. Advani serves as the director of the inpatient leukemia program at the Tosset Canc…
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Marina Parry and Gerhardt Attard join Alicia Morgans in discussing two key studies from the STAMPEDE trial platform, including “Comparison of abiraterone acetate and prednisolone or combination enzalutamide + abiraterone acetate and prednisolone for metastatic hormone-sensitive prostate cancer (mHSPC) starting ADT: overall survival (OS) results of 2 randomized Phase III trials from the STAMPEDE…
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1New Vaccine Significantly Improved Lifespan of Patients With Multiple Myeloma in Phase 1 Trial - 7 month(s) ago
Most patients had improved clinical response within 90 days of receiving the dendritic cell vaccine and ASCT.
Source: www.pharmacytimes.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0Study Suggests Base-Edited T Cells Could Minimize Immunotherapy Complications in Leukemia Treatment - 7 month(s) ago
The use of base editing to generate universal, off-the-shelf CAR T cells is a promising approach for relapsed leukemia, with potential implications for the future of gene therapy.
Source: www.pharmacytimes.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0Researchers Rule Out Gefapixant to Help Unexplained Chronic Cough - 7 month(s) ago
The use of gefapixant reduces cough frequency but increases adverse events in individuals suffering from a chronic cough.
Source: www.pharmacytimes.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 1Recommendations for the use of pediatric data in artificial intelligence and machine learning ACCEPT-AI - 8 month(s) ago
npj Digital Medicine – Recommendations for the use of pediatric data in artificial intelligence and machine learning ACCEPT-AI
Source: www.nature.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1The Efficacy of First-Line Carboplatin in Metastatic Urothelial Carcinoma - Expert Commentary - 8 month(s) ago
KEYNOTE-361 study, advanced or metastatic urothelial carcinoma (AMUC), DANUBE study, carboplatin-based chemotherapy versus ICI monotherapy, Metastatic Urothelial Carcinoma, IMvigor130 study.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
Aims Adenomas of the ciliary body epithelium, including adenoma of the pigmented ciliary body epithelium (APCE) and adenoma of the non-pigmented ciliary body epithelium (ANPCE), are extremely rare, and most knowledge about them comes from sporadic case reports. The purpose of this study was to provide a comprehensive understanding of adenomas of the ciliary body epithelium and to identify the similarities and differences between APCE and ANPCE. Methods This study was a retrospective case series comprising data from 41 patients obtained from retrieved publications and five cases diagnosed at the Shanghai Ninth People’s Hospital. The clinicopathological features, treatment and prognosis of APCE and ANPCE were compared using the non-parametric rank sum test, t-test and the χ2 test. Results The clinical and histopathological features and treatment were analogous between APCE (n=23) and ANPCE (n=23). The overall visual prognosis associated with the two tumours was good, with 63% of the pati
Source: bjo.bmj.comCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 02023 ASH ALL Inotuzumab Update [Slides] - Van Huynh, MD MOASC - 9 month(s) ago
Inotuzumab, GMALL, Ponatinib & Blinatumomab ASH Updates in Acute Lymphoblastic Leukemia By Van Huynh, MD Updates in acute lymphoblastic leukemia that was presented at ASH in New Orleans. So I think there were so many great talks. There were so many great talks and I decided I would focus on just three and really…
Source: oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🚀 #ASH22 Updates in ALL Immunotherapy with Inotuzumab! Van Huynh, MD @MOASC_Office @UCIrvineHealth, shared insights at #MOASC23. 🩺 Discover remarkable breakthroughs![Video]🎥: https://t.co/BBlUqPvBAS 💊 #oncology #leukemia #medicalresearch #Immunotherapy #UCIMedSchool #CARTcell https://t.co/OSKdxJCTLI
-
Check out the latest Clinical Pediatrics special issue on Additional Respiratory Infectious Disease Concerns. Explpre reports and articles covering various topics in pediatric infectious diseases. Read it here: https://t.co/3kLfIGcaK7 #MedicalResearch